Neogen Corporation
Description
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
About
CEO
Mr. John Edward Adent
Employees
2,917
Instrument type
Common Stock
Sector
Healthcare
Industry
Diagnostics & Research
MIC code
XNGS
Address
620 Lesher Place, Lansing, MI 48912-1595, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Jan 8, 2026 | — | — | — | — |
| Oct 8, 2025 | — | — | — | — |
| Jul 28, 2025 | — | — | — | — |
| Apr 7, 2025 | — | — | — | — |
| Jan 10, 2025 | 0.10 | 0.11 | 0.01 | 10.00% |
Earnings estimate
|
Current Quarter
(Feb 2025)
|
Next Quarter
(May 2025)
|
Current Year
(May 2025)
|
Next Year
(May 2026)
|
|
|---|---|---|---|---|
| Number of analysts | 2 | 2 | 2 | 2 |
| Average estimate | 0.12 | 0.13 | 0.43 | 0.49 |
| Low estimate | 0.11 | 0.12 | 0.41 | 0.42 |
| High estimate | 0.12 | 0.14 | 0.44 | 0.55 |
| Last year EPS | 0.12 | 0.10 | 0.45 | 0.43 |
[stock_revenue_estimate]
Growth estimates
Current qtr (Feb 2025)
-4.170%
Next qtr. (May 2025)
30.000%
Current year (May 2025)
-5.560%
Next year (May 2026)
14.120%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fiscal date | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 |
| Total reported revenue | 924.22M | 822.45M | 527.16M | 468.46M | 418.17M |
| Cost of revenue | 460.32M | 416.49M | 284.15M | 253.40M | 221.89M |
| Gross profit | 463.90M | 405.96M | 243.01M | 215.06M | 196.28M |
| Operating expense | |||||
| Research & development | 22.48M | 26.04M | 17.05M | 16.25M | 14.75M |
| Selling general and admin | 382.76M | 342.40M | 167.35M | 124.64M | 114.01M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 58.66M | 37.52M | 58.62M | 74.17M | 67.52M |
| Non operating interest income | |||||
| Income | 6.36M | 3.17M | 1.34M | 1.69M | 5.99M |
| Expense | 73.39M | 55.96M | 72,000 | 78,000 | — |
| Other income expense | -5.94M | -6.76M | 322,000 | -515,000 | -1.21M |
| Pretax income | -14.31M | -22.04M | 60.21M | 75.27M | 72.31M |
| Tax provision | -4.88M | 828,000 | 11.90M | 14.39M | 12.83M |
| Net income | -9.42M | -22.87M | 48.31M | 60.88M | 59.48M |
| Basic EPS | -0.04 | -0.12 | 0.45 | 0.57 | 0.56 |
| Diluted EPS | -0.04 | -0.12 | 0.45 | 0.57 | 0.56 |
| Basic average shares | 216.48M | 188.88M | 107.80M | 107.47M | 105.72M |
| Diluted average shares | 216.48M | 188.88M | 107.80M | 107.47M | 105.72M |
| EBITDA | 180.32M | 124.39M | 84.41M | 96.39M | 85.92M |
| Net income from continuing op. | -9.42M | -22.87M | 48.31M | 60.88M | 59.48M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fiscal date | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 |
| Total assets | 4.55B | 4.55B | 992.93M | 920.19M | 797.18M |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 170.61M | 163.24M | 44.47M | 75.60M | 66.27M |
| Other short term investments | 325,000 | 82.33M | 336.58M | 305.49M | 277.40M |
| Accounts receivable | 173.01M | 153.25M | 99.67M | 91.82M | 84.68M |
| Other receivables | — | — | — | — | — |
| Inventory | 189.27M | 133.81M | 122.31M | 100.70M | 95.05M |
| Prepaid assets | — | — | 23.76M | 17.84M | 14.00M |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 56.03M | 53.30M | 23.76M | 17.84M | 14.00M |
| Non current assets | |||||
| Properties | 14.79M | 11.93M | 3.18M | 2.48M | 1.95M |
| Land and improvements | 10.50M | 10.21M | 9.49M | 7.78M | 5.46M |
| Machinery furniture equipment | 184.63M | 159.63M | 120.49M | 114.46M | 94.68M |
| Construction in progress | 113.97M | 52.24M | 5.97M | 3.26M | 4.97M |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -140.29M | -120.12M | -104.88M | -97.81M | -75.31M |
| Goodwill | 5.78B | 5.88B | 392.91M | 355.27M | 287.26M |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 1.51B | 1.61B | 107.50M | 92.32M | 66.58M |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 20.43M | 15.22M | 2.16M | 2.02M | 2.23M |
| Total liabilities | 1.40B | 1.42B | 105.56M | 79.82M | 72.01M |
| Current liabilities | |||||
| Accounts payable | 83.06M | 76.67M | 34.61M | 23.90M | 25.65M |
| Accrued expenses | 10.99M | 11.15M | 24.52M | 13.20M | 13.65M |
| Short term debt | 2.45M | — | — | — | — |
| Deferred revenue | 4.63M | 4.62M | 5.46M | 3.40M | — |
| Tax payable | 10.45M | 6.95M | 2.13M | 1.85M | 1.46M |
| Pensions | 19.95M | 25.15M | 11.12M | 11.25M | 7.74M |
| Other current liabilities | 22.80M | 20.93M | — | — | — |
| Non current liabilities | |||||
| Long term debt | 888.39M | 885.44M | — | — | — |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | 326.72M | 353.43M | 17.01M | 21.92M | 18.13M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 35.26M | 35.88M | 10.70M | 4.30M | 5.39M |
| Shareholders equity | |||||
| Common stock | 34.66M | 34.60M | 17.25M | 17.20M | 16.94M |
| Retained earnings | 555.62M | 565.04M | 587.91M | 539.60M | 478.72M |
| Other shareholders equity | -30.02M | -33.25M | -27.77M | -11.38M | -19.71M |
| Total shareholders equity | 3.14B | 3.13B | 887.37M | 840.38M | 725.18M |
| Additional paid in capital | 2.58B | 2.57B | 309.98M | 294.95M | 249.22M |
| Treasury stock | — | — | — | — | — |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||
| Net Income | -9.42M | -22.87M | 48.31M | 60.88M | 59.48M | 60.18M | 63.22M | 43.97M | 36.54M | 33.58M | 28.03M | 27.04M | 22.39M | 22.80M | 17.52M | 13.87M | 12.10M | 9.13M | 7.94M | 5.92M | 5.10M | 4.79M | 3.95M | 3.17M | 3.07M | 2.30M | 2.20M | 1.80M | -200,000 | 700,000 | 900,000 | -500,000 | -800,000 |
| Depreciation | 121.23M | 90.47M | 24.13M | 21.04M | 18.40M | 17.62M | 17.06M | 14.69M | 12.18M | 10.65M | 9.18M | 7.41M | 6.17M | 5.33M | 4.44M | 3.89M | 3.52M | 2.84M | 2.42M | 1.70M | 1.40M | 1.14M | 1.07M | 1.30M | 946,000 | 900,000 | 700,000 | 600,000 | 500,000 | 500,000 | 400,000 | 300,000 | 300,000 |
| Deferred Taxes | -27.42M | -19.23M | -4.70M | -640,000 | 1.60M | 1.20M | -3.00M | -292,000 | 1.91M | 496,000 | -542,000 | 287,000 | 1.34M | 2.25M | -200,000 | 1.55M | 450,000 | 813,000 | 485,000 | 309,000 | 512,000 | 420,000 | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | 13.77M | 10.18M | 7.15M | 6.44M | 6.47M | 5.54M | 4.91M | 5.26M | 5.47M | 4.45M | 3.69M | 3.06M | 2.46M | 2.24M | 2.24M | 1.97M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | 8.72M | 7.16M | -2.44M | — | — | — | — | — | — | — | — | — | — | — | -207,000 | — | 1.15M | 833,000 | 703,000 | — | — | — | — | — | -1,000 | — | 100,000 | — | -100,000 | -100,000 | -200,000 | -100,000 | -100,000 |
| Accounts Receivable | -20.10M | -53.88M | -7.80M | -2.60M | -2.88M | -4.03M | -10.23M | 5.04M | -6.00M | -7.25M | -10.60M | -2.67M | -7.20M | -903,000 | -2.24M | -4.08M | -3.87M | -1.80M | -1.35M | -545,000 | -2.23M | -755,000 | -128,000 | -568,000 | -736,000 | -300,000 | -600,000 | -400,000 | — | -400,000 | -100,000 | — | -100,000 |
| Accounts Payable | 13.75M | 18.64M | 20.24M | -2.22M | 6.75M | -1.46M | 4.38M | -1.69M | 704,000 | 412,000 | 1.97M | -1.42M | 2.33M | 1.20M | 3.01M | -2.65M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | -77.28M | 10.11M | -12.81M | 1.57M | -10.01M | -10.44M | -2.65M | -6.97M | -9.43M | 319,000 | -3.53M | -2.08M | -3.09M | -434,000 | 64,000 | -3.70M | -7.26M | -3.14M | 2.90M | -476,000 | -1.26M | -280,000 | -2.02M | -137,000 | 543,000 | -100,000 | -600,000 | — | 900,000 | -1.10M | 400,000 | — | — |
| Operating Cash Flow | 23.24M | 40.58M | 72.09M | 84.48M | 79.79M | 68.62M | 73.69M | 60.01M | 41.37M | 42.65M | 28.19M | 31.63M | 24.39M | 32.47M | 24.62M | 10.86M | 6.08M | 8.67M | 13.10M | 6.91M | 3.53M | 5.31M | 2.87M | 3.77M | 3.83M | 2.80M | 1.80M | 2.00M | 1.10M | -400,000 | 1.40M | -300,000 | -700,000 |
| Investing Activities | |||||||||||||||||||||||||||||||||
| Capital Expenditures | -111.31M | -64.93M | -24.43M | -26.71M | -24.05M | -14.66M | -20.95M | -14.58M | -14.22M | -9.62M | -11.54M | -8.90M | -12.41M | -7.80M | -5.43M | -2.84M | -2.47M | -4.70M | -2.69M | -2.69M | -5.04M | -2.46M | -1.72M | -1.10M | -920,000 | -900,000 | -600,000 | -700,000 | -1.10M | -400,000 | -200,000 | -100,000 | -200,000 |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | — | 11.72M | -38.75M | -50.77M | -13.16M | -6.39M | -468,000 | -34.03M | -42.49M | -6.55M | -39.27M | -13.32M | -4.01M | — | -20.30M | -11.13M | -10.15M | — | -20.66M | -874,000 | -10.03M | -1.85M | -3.59M | -4.75M | -2.65M | — | — | — | — | — | — | — | — |
| Purchase of Investments | — | -12.52M | -415.89M | -792.68M | -458.30M | -437.32M | -361.42M | -162.76M | -151.63M | -105.94M | -91.69M | -82.78M | -71.63M | -60.32M | — | — | — | — | -6.68M | -500,000 | -31.51M | -44.68M | -28.18M | -8.26M | -30.28M | -25.10M | -23.10M | -22.70M | — | — | -8.30M | -7.80M | -15.10M |
| Sale of Investments | 82.00M | 266.77M | 381.84M | 764.60M | 406.73M | 339.23M | 299.75M | 149.23M | 147.19M | 93.66M | 91.21M | 67.04M | 72.27M | 40.08M | — | — | — | — | 6.53M | 831,000 | 39.02M | 41.18M | 30.17M | 10.40M | 31.42M | 25.40M | 25.60M | 11.90M | — | — | 6.90M | 9.30M | 16.10M |
| Investing Cash Flow | -29.31M | 201.04M | -97.23M | -105.56M | -88.79M | -119.15M | -83.08M | -62.14M | -61.15M | -28.46M | -51.29M | -37.95M | -15.79M | -28.04M | -25.73M | -13.97M | -12.62M | -4.70M | -23.50M | -3.23M | -7.57M | -7.81M | -3.31M | -3.71M | -2.44M | -1.20M | -1.80M | -11.40M | -1.10M | -1.20M | -1.60M | 500,000 | 800,000 |
| Financing Activities | |||||||||||||||||||||||||||||||||
| Long-Term Debt Issuance | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 100,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | — | -100.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | -118,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Financing Charges | -538,000 | -19.28M | -1.12M | -1.09M | — | — | -423,000 | 3.92M | 2.95M | 2.48M | 4.76M | 3.11M | 1.83M | 2.99M | 709,000 | 682,000 | 531,000 | 460,000 | — | 250,000 | — | — | — | — | 1,000 | — | 100,000 | — | — | -100,000 | — | — | — |
| Financing Cash Flow | -538,000 | -119.28M | -1.12M | -1.09M | — | -3.14M | -423,000 | 3.92M | 2.95M | 2.48M | 4.76M | 3.11M | 1.83M | 2.99M | 809,000 | -359,000 | 5.59M | 15.90M | 1.07M | 1.02M | 995,000 | 154,000 | 1.16M | 363,000 | -1.06M | -2.10M | 400,000 | 10.30M | 300,000 | 100,000 | 100,000 | 200,000 | 100,000 |
| Other Cash Details | |||||||||||||||||||||||||||||||||
| End Cash Position | 170.61M | 163.24M | 44.47M | 75.60M | 66.27M | 41.69M | 83.07M | 77.57M | 55.26M | 66.06M | 40.68M | 50.03M | 49.05M | 35.84M | 22.81M | 13.84M | 14.27M | 13.42M | 1.81M | 1.97M | 1.37M | 1.06M | 2.01M | 848,000 | 2.20M | 1.10M | 700,000 | — | — | — | — | — | — |
| Income Tax Paid | 22.30M | 15.47M | 17.24M | 14.97M | 7.36M | 13.03M | 14.97M | 17.70M | 13.41M | 10.45M | -9.96M | 8.99M | 6.45M | 9.86M | 6.28M | 7.39M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | 73.17M | 42.62M | 72,000 | 78,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | -76.16M | -24.73M | 43.61M | 54.38M | 61.83M | 49.18M | 48.19M | 45.70M | 21.11M | 34.17M | 10.13M | 17.66M | 9.86M | 21.05M | 22.56M | 8.15M | 5.40M | 5.45M | 9.62M | 4.03M | -2.06M | 4.24M | 1.68M | 1.40M | 3.76M | 2.80M | 900,000 | 1.60M | -200,000 | -1.10M | 1.50M | -600,000 | -900,000 |
Error: Invalid format in Holders JSON file.
Article
Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors
Vertiv Holdings Co. excels with strong AI-related data center demand, projecting 16%-18% organic revenue growth for 2025, and increased profit margins. Chart Industries, Inc. shows robust fundamentals with record revenue and margins, expecting 12% revenue and 18% EBITDA growth in 2025. Intapp, Inc. benefits from strong quarterly results, 17% revenue growth, and a record pipeline, driven by AI product demand and favorable M&A activity.
Jan 31, 2025
Article
Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk
LINCOLN, Neb. , Jan. 21, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food security solutions, announced today the launch of Igenity® BCHF to improve overall bovine heart health standards.
Jan 21, 2025
Article
NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit
Neogen launches the new Molecular Detection Assay 2 - Quantitative Salmonella (MDA2QSAL96) to deliver consistency and sensitivity with an easy-to-use workflow that saves time and resources.
Jan 17, 2025
